789 results on '"Keniry A"'
Search Results
152. Xmas ESC: A new female embryonic stem cell system that reveals the BAF complex as a key regulator of the establishment of X chromosome inactivation
- Author
-
Keniry, Andrew, primary, Jansz, Natasha, additional, Gearing, Linden J., additional, Wanigasuriya, Iromi, additional, Chen, Joseph, additional, Nefzger, Christian M., additional, Hickey, Peter F., additional, Gouil, Quentin, additional, Liu, Joy, additional, Breslin, Kelsey A., additional, Iminitoff, Megan, additional, Beck, Tamara, additional, Tapia del Fierro, Andres, additional, Whitehead, Lachlan, additional, Kinkel, Sarah A., additional, Taberlay, Phillippa C., additional, Willson, Tracy, additional, Pakusch, Miha, additional, Ritchie, Matthew E., additional, Hilton, Douglas J., additional, Polo, Jose M., additional, and Blewitt, Marnie E., additional
- Published
- 2019
- Full Text
- View/download PDF
153. Biodiversity Takes Center Stage: Frames for Learning during the Mars Race
- Author
-
Keniry, L. Julian, primary
- Published
- 2019
- Full Text
- View/download PDF
154. Using long-read sequencing to detect imprinted DNA methylation
- Author
-
Gigante, Scott, primary, Gouil, Quentin, additional, Lucattini, Alexis, additional, Keniry, Andrew, additional, Beck, Tamara, additional, Tinning, Matthew, additional, Gordon, Lavinia, additional, Woodruff, Chris, additional, Speed, Terence P, additional, Blewitt, Marnie E, additional, and Ritchie, Matthew E, additional
- Published
- 2019
- Full Text
- View/download PDF
155. Changes in Catholic Identity at Mayo Clinic Rochester: Isolated Event or Sign of the Times?
- Author
-
Swetz, Keith M., Frederick, B. Lynn, Oviatt, Jonathan J., and Keniry, Margaret Jean
- Published
- 2013
- Full Text
- View/download PDF
156. Structural Investigation of the Hedamycin:d(ACCGGT)2 Complex by NMR and Restrained Molecular Dynamics
- Author
-
Owen, Elisabeth A., Burley, Glenn A., Carver, John A., Wickham, Geoffrey, and Keniry, Max A.
- Published
- 2002
- Full Text
- View/download PDF
157. Identification of Chemical Compounds That Inhibit the Function of Glutamyl-tRNA Synthetase from Pseudomonas aeruginosa
- Author
-
Edgar Guerrero, James M. Bullard, Joel Manrrique, Yanmei Hu, and Megan Keniry
- Subjects
Molecular Sequence Data ,Drug Evaluation, Preclinical ,Aminoacylation ,Biology ,medicine.disease_cause ,Biochemistry ,Article ,Analytical Chemistry ,Inhibitory Concentration 50 ,Mice ,Minimum inhibitory concentration ,Bacterial Proteins ,Glutamate—tRNA ligase ,medicine ,Animals ,TRNA aminoacylation ,Amino Acid Sequence ,Escherichia coli ,Enzyme Assays ,Glutamic acid ,biology.organism_classification ,Molecular biology ,Anti-Bacterial Agents ,High-Throughput Screening Assays ,Glutamate-tRNA Ligase ,Kinetics ,Scintillation proximity assay ,Pseudomonas aeruginosa ,NIH 3T3 Cells ,Molecular Medicine ,Bacteria ,Biotechnology - Abstract
Pseudomonas aeruginosa glutamyl-tRNA synthetase (GluRS) was overexpressed in Escherichia coli. Sequence analysis indicated that P. aeruginosa GluRS is a discriminating GluRS and, similar to other GluRS proteins, requires the presence of tRNA(Glu) to produce a glutamyl-AMP intermediate. Kinetic parameters for interaction with tRNA were determined and the k(cat) and KM were 0.8 s(-1) and 0.68 µM, respectively, resulting in a k(cat)/KM of 1.18 s(-1) µM(-1). A robust aminoacylation-based scintillation proximity assay (SPA) assay was developed and 800 natural products and 890 synthetic compounds were screened for inhibitory activity against P. aeruginosa GluRS. Fourteen compounds with inhibitory activity were identified. IC50s were in the low micromolar range. The minimum inhibitory concentration (MIC) was determined for each of the compounds against a panel of pathogenic bacteria. Two compounds, BT_03F04 and BT_04B09, inhibited GluRS with IC50s of 21.9 and 24.9 µM, respectively, and both exhibited promising MICs against Gram-positive bacteria. Time-kill studies indicated that one compound was bactericidal and one was bacteriostatic against Gram-positive bacteria. BT_03F04 was found to be noncompetitive with both ATP and glutamic acid, and BT_04B09 was competitive with glutamic acid but noncompetitive with ATP. The compounds were not observed to be toxic to mammalian cells in MTT assays.
- Published
- 2015
- Full Text
- View/download PDF
158. Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2
- Author
-
Joy Liu, Omer Gilan, Marnie E. Blewitt, Ian J. Majewski, Alicia Oshlack, Mark A. Dawson, Sarah Kinkel, Darcy Moore, Andrew Keniry, Christoffer Flensburg, Linden J. Gearing, Roman Galeev, Jonas Larsson, Kelsey Breslin, Warren S. Alexander, Stanley Chun-Wei Lee, and Kelan Chen
- Subjects
Hematopoiesis and Stem Cells ,Immunology ,Antigens, CD34 ,macromolecular substances ,Biology ,Biochemistry ,Mice ,medicine ,SUZ12 ,Animals ,Humans ,Cell Lineage ,RNA, Small Interfering ,Progenitor cell ,Regulation of gene expression ,Gene Expression Profiling ,Stem Cells ,Polycomb Repressive Complex 2 ,Hematopoietic stem cell ,Histone-Lysine N-Methyltransferase ,Cell Biology ,Hematology ,Hematopoietic Stem Cells ,Embryonic stem cell ,Molecular biology ,Hematopoiesis ,Cell biology ,Gene Expression Regulation, Neoplastic ,Mice, Inbred C57BL ,Transplantation ,Haematopoiesis ,Phenotype ,medicine.anatomical_structure ,Liver ,Stem cell ,Neoplasm Transplantation - Abstract
Polycomb repressive complex 2 (PRC2) plays a key role in hematopoietic stem and progenitor cell (HSPC) function. Analyses of mouse mutants harboring deletions of core components have implicated PRC2 in fine-tuning multiple pathways that instruct HSPC behavior, yet how PRC2 is targeted to specific genomic loci within HSPCs remains unknown. Here we use short hairpin RNA-mediated knockdown to survey the function of PRC2 accessory factors that were defined in embryonic stem cells (ESCs) by testing the competitive reconstitution capacity of transduced murine HSPCs. We find that, similar to the phenotype observed upon depletion of core subunit Suz12, depleting Jarid2 enhances the competitive transplantation capacity of both fetal and adult mouse HSPCs. Furthermore, we demonstrate that depletion of JARID2 enhances the in vitro expansion and in vivo reconstitution capacity of human HSPCs. Gene expression profiling revealed common Suz12 and Jarid2 target genes that are enriched for the H3K27me3 mark established by PRC2. These data implicate Jarid2 as an important component of PRC2 that has a central role in coordinating HSPC function.
- Published
- 2015
- Full Text
- View/download PDF
159. Using long-read sequencing to detect imprinted DNA methylation
- Author
-
Gigante, S, Gouil, Q, Lucattini, A, Keniry, A, Beck, T, Tinning, M, Gordon, L, Woodruff, C, Speed, TP, Blewitt, ME, Ritchie, ME, Gigante, S, Gouil, Q, Lucattini, A, Keniry, A, Beck, T, Tinning, M, Gordon, L, Woodruff, C, Speed, TP, Blewitt, ME, and Ritchie, ME
- Abstract
Systematic variation in the methylation of cytosines at CpG sites plays a critical role in early development of humans and other mammals. Of particular interest are regions of differential methylation between parental alleles, as these often dictate monoallelic gene expression, resulting in parent of origin specific control of the embryonic transcriptome and subsequent development, in a phenomenon known as genomic imprinting. Using long-read nanopore sequencing we show that, with an average genomic coverage of ∼10, it is possible to determine both the level of methylation of CpG sites and the haplotype from which each read arises. The long-read property is exploited to characterize, using novel methods, both methylation and haplotype for reads that have reduced basecalling precision compared to Sanger sequencing. We validate the analysis both through comparison of nanopore-derived methylation patterns with those from Reduced Representation Bisulfite Sequencing data and through comparison with previously reported data. Our analysis successfully identifies known imprinting control regions (ICRs) as well as some novel differentially methylated regions which, due to their proximity to hitherto unknown monoallelically expressed genes, may represent new ICRs.
- Published
- 2019
160. Latest techniques to study DNA methylation
- Author
-
Blewitt, M, Gouil, Q, Keniry, A, Blewitt, M, Gouil, Q, and Keniry, A
- Abstract
Bisulfite sequencing is a powerful technique to detect 5-methylcytosine in DNA that has immensely contributed to our understanding of epigenetic regulation in plants and animals. Meanwhile, research on other base modifications, including 6-methyladenine and 4-methylcytosine that are frequent in prokaryotes, has been impeded by the lack of a comparable technique. Bisulfite sequencing also suffers from a number of drawbacks that are difficult to surmount, among which DNA degradation, lack of specificity, or short reads with low sequence diversity. In this review, we explore the recent refinements to bisulfite sequencing protocols that enable targeting genomic regions of interest, detecting derivatives of 5-methylcytosine, and mapping single-cell methylomes. We then present the unique advantage of long-read sequencing in detecting base modifications in native DNA and highlight the respective strengths and weaknesses of PacBio and Nanopore sequencing for this application. Although analysing epigenetic data from long-read platforms remains challenging, the ability to detect various modified bases from a universal sample preparation, in addition to the mapping and phasing advantages of the longer read lengths, provide long-read sequencing with a decisive edge over short-read bisulfite sequencing for an expanding number of applications across kingdoms.
- Published
- 2019
161. Analysis of Histone Modifications in Acute Myeloid Leukaemia Using Chromatin Immunoprecipitation
- Author
-
Benjamin J, Shields, Andrew, Keniry, Marnie E, Blewitt, and Matthew P, McCormack
- Subjects
Histones ,Chromatin Immunoprecipitation ,Leukemia, Myeloid, Acute ,High-Throughput Nucleotide Sequencing ,Humans ,Sequence Analysis, DNA ,Polymerase Chain Reaction ,Protein Processing, Post-Translational - Abstract
Chromatin Immunoprecipitation (ChIP) using antibodies specific for histone modifications is a powerful technique for assessing the epigenetic states of cell populations by either quantitative PCR (ChIP-PCR) or next generation sequencing analysis (ChIP-Seq). Here we describe the procedure for ChIP of histone marks in myeloid leukaemia cell lines and the subsequent purification of genomic DNA associated with repressive and activating histone modifications for further analysis. This procedure can be widely applied to a variety of histone marks to assess both activating and repressive modifications in the context of myeloid leukaemia.
- Published
- 2018
162. Analysis of Histone Modifications in Acute Myeloid Leukaemia Using Chromatin Immunoprecipitation
- Author
-
Benjamin J. Shields, Andrew Keniry, Matthew P. McCormack, and Marnie E. Blewitt
- Subjects
0301 basic medicine ,Myeloid ,Immunoprecipitation ,Context (language use) ,Biology ,Chromatin ,Cell biology ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,medicine.anatomical_structure ,Histone ,chemistry ,hemic and lymphatic diseases ,medicine ,biology.protein ,Epigenetics ,Chromatin immunoprecipitation ,DNA - Abstract
Chromatin Immunoprecipitation (ChIP) using antibodies specific for histone modifications is a powerful technique for assessing the epigenetic states of cell populations by either quantitative PCR (ChIP-PCR) or next generation sequencing analysis (ChIP-Seq). Here we describe the procedure for ChIP of histone marks in myeloid leukaemia cell lines and the subsequent purification of genomic DNA associated with repressive and activating histone modifications for further analysis. This procedure can be widely applied to a variety of histone marks to assess both activating and repressive modifications in the context of myeloid leukaemia.
- Published
- 2018
- Full Text
- View/download PDF
163. Studying X chromosome inactivation in the single-cell genomic era
- Author
-
Marnie E. Blewitt and Andrew Keniry
- Subjects
0301 basic medicine ,Epigenetic Process ,Dosage compensation ,Transcription, Genetic ,Genomics ,Computational biology ,Biology ,Biochemistry ,X-inactivation ,Chromatin ,Epigenesis, Genetic ,03 medical and health sciences ,030104 developmental biology ,X Chromosome Inactivation ,Dosage Compensation, Genetic ,DNA methylation ,Gene silencing ,Animals ,Humans ,Epigenetics ,Gene Silencing - Abstract
Single-cell genomics is set to revolutionise our understanding of how epigenetic silencing works; by studying specific epigenetic marks or chromatin conformations in single cells, it is possible to ask whether they cause transcriptional silencing or are instead a consequence of the silent state. Here, we review what single-cell genomics has revealed about X chromosome inactivation, perhaps the best characterised mammalian epigenetic process, highlighting the novel findings and important differences between mouse and human X inactivation uncovered through these studies. We consider what fundamental questions these techniques are set to answer in coming years and propose that X chromosome inactivation is an ideal model to study gene silencing by single-cell genomics as technical limitations are minimised through the co-analysis of hundreds of genes.
- Published
- 2017
164. Genome-wide association study identifies eight loci associated with blood pressure
- Author
-
Peter Holmans, Udo Seedorf, Beverley M. Shields, Peter McGruffin, Arne Pfeufer, Steve Eyre, Nathalie J. Prescott, Michael Boehnke, Valentina Moskovina, Abiodun Onipinla, Leena Peltonen, Nadira Yuldasheva, Peter M. Nilsson, Valeria Romanazzi, Vincent Mooser, Göran Berglund, Alistair S. Hall, Dominic P. Kwiatkowski, Barry Widmer, Benjamin F. Voight, Stefania Bandinelli, Mark M. Iles, Sven Bergmann, Thomas Meitinger, James P. Boorman, Simonetta Guarrera, Nazneen Rahman, Murielle Bochud, Graham A. Hitman, Emma Keniry, Nelson B. Freimer, Richard Dobson, Francis S. Collins, Gerjan Navis, Jennifer L. Pointon, Richard N. Bergman, Ruth J. F. Loos, Roberto Lorbeer, Carolina A. Braga Marcano, Christian Gieger, Florian Ernst, Xin Yuan, Catherine Potter, Hazel E. Drummond, Allan H. Young, George Kirov, John F. Peden, Helen Stevens, David Clayton, Mattijs E. Numans, Katherine Gordon-Smith, Anne Farmer, Alastair Forbes, M. Khalid Mohiuddin, John A. Todd, Christopher G. Mathew, David A. Collier, Mark I. McCarthy, Francesca Bredin, Clive M. Onnie, Dan Davidson, Markus Perola, Pamela Whittaker, Yvonne T. van der Schouw, Rathi Ravindrarajan, I. C.A. Spencer, Teresa Ferreira, Nilesh J. Samani, Serge Hercberg, Gonçalo R. Abecasis, Christopher J. Groves, Nicholas John Craddock, Angela Döring, Edward G. Lakatta, Muminatou Jallow, Wendy L. McArdle, David Bentley, Susana Eyheramendy, Uwe Völker, Christopher Newton-Cheh, Jaspal S. Kooner, Hugh Watkins, Gavin Lucas, H. T. Leung, Marjo Ritta Jarvelin, Johanna Kuusisto, Wiek H. van Gilst, Wendy Thomson, Lou R. Cardon, Harold Snieder, Marju Orho-Melander, Patricia B. Munroe, Toshiko Tanaka, Jeffrey C. Barrett, Azhar Maqbool, Henry Völzke, John M. C. Connell, Elaine R. Nimmo, John R. B. Perry, Michael R. Stratton, Ralph McGinnis, Pekka Jousilahti, Michiel L. Bots, Ian Jones, Elizabeth Meech, Matthew A. Brown, Johannie Gungadoo, Jian'an Luan, Jilur Ghori, Richard J. Dixon, N. Charlotte Onland-Moret, Fulvio Ricceri, Anthony J. Balmforth, Catherine E. Todhunter, Inês Barroso, Sheila Bingham, Timo T. Valle, Fredrik O. Vannberg, Diana Zelenika, Stephen Sawcer, Anneli Pouta, David M. Evans, Cuno S. P. M. Uiterwaal, Pilar Galan, Georg Homuth, Hannah Donovan, David J. Conway, Paul Elliott, Alessandra Allione, Paul E. de Jong, Miles Parkes, Amy Chaney, John C. Chambers, Toby Johnson, Isaac Subirana, Vesela Gateva, Cathryn M. Lewis, Christopher J. O'Donnell, Hana Lango, David Schlessinger, Mark J. Caulfield, Thorsten Reffelmann, Jamie Barbour, Karen L. Mohlke, Sarah E. Hunt, Thilo Winzer, Frances M K Williams, Christopher Mathew, I. Wallace, Anuj Goel, Jaakko Tuomilehto, Louise V. Wain, Gabriel Crawford, Samantha L. Hider, Detelinea Grozeva, Elaine K. Green, Paul D. Gilbert, Peter S. Braund, Jaume Marrugat, Rainer Rettig, Pim van der Harst, Yik Ying Teo, Andrew P. Morris, Guiseppe Matullo, Serena Sanna, Cristen J. Willer, Suzannah Bumpstead, Niall C. Taylor, Jacques S. Beckmann, Pierre Meneton, Elin Org, Luigi Ferrucci, Doug Easton, Sheila Seal, Joanne M. Heward, Anne U. Jackson, Eleftheria Zeggini, Rachel M. Freathy, Maris Laan, Paul Wordsworth, Sarah Nutland, Kerstin Koch, Sian Ceasar, Anders Hamsten, Judith M. Hussey, Tariq Ahmad, Derek P. Jewell, Paul Scheet, Charlie W. Lees, C Farrar, Christopher Prowse, Markku Laakso, David St Clair, Kate Downes, Diederick E. Grobbee, Paul Burton, Simon C. Potter, Ian N. Bruce, Tim D. Spector, Anne Barton, H.-Erich Wichmann, Matthew J. Simmonds, David Hadley, Cecilia M. Lindgren, Gérard Waeber, Nigel W. Rayner, Melanie J. Newport, Manjinder S. Sandhu, Audrey Duncanson, Guangju Zhai, Simon Heath, Susan M. Ring, Alessandra Di Gregorio, Richard Williamson, Nicholas J. Wareham, Zhan Su, Olle Melander, John R. Thompson, Alexander Teumer, Sheila A. Fisher, Lachlan J. M. Coin, Leif Groop, Giovanni Tognoni, Amanda Elkin, Alan J. Silman, Jack Satsangi, Jane Worthington, Martin Farrall, John Webster, Niall Cardin, Neil Walker, Anna F. Dominiczak, Jeremy D. Sanderson, Damjan Vukcevic, Bryan Howie, Silvia Polidoro, Stephen G. Ball, Mark Tremelling, Stephen Newhouse, Stephen M. Schwartz, Lori L. Bonnycastle, Chris Wallace, Kijoung Song, Mario A. Morken, I. Nicol Ferrier, Beverley Barke, Paolo Vineis, Manuela Uda, Deborah P M Symmons, Emily J. Lyons, Mingzhan Xue, Timothy M. Frayling, Stephen C.L. Cough, David Withers, Adrian V. S. Hill, Suzanne Stevens, Jennifer Jolley, Marcus Dörr, Kirk A. Rockett, David B. Dunger, Mark Walker, Jayne A. Franklyn, Lisa Jones, David S. Siscovick, Ann-Christine Syvänen, Laura J. Scott, Morris J. Brown, Barbera Cant, Michael Inouye, Feng Zhang, Carlotta Sacerdote, Katherine S. Elliott, Jonathan Marchini, Peter Donnely, Michael John Owen, An Goris, Marcus Prembey, Andrew T. Hattersley, Gerome Breen, Marian L. Hamshere, Thomas Illig, Samer S. Najjar, Nicole Soranzo, Kay-Tee Khaw, Graham R. Walters, Willem H. Ouwehand, David P. Strachan, Martin D. Tobin, Alastair Compston, John C. Mansfield, David Altshuler, Salvatore Panico, Sekar Kathiresan, Dawn M. Waterworth, Michael N. Weedon, D. Timothy Bishop, Claire Bryan, Alexandra S. Knight, Kate L. Lee, Paul F. O'Reilly, Massimo Mangino, Michael Conlon O'Donovan, Jing Hua Zhao, Konstantinos A. Papadakis, Jennifer H. Barrett, Joanne Pereira-Gale, N J Timpson, Stephan B. Felix, Panos Deloukas, Nicholas A. Watkins, Anna-Liisa Hartikainen, Peter Vollenweider, Richard Jones, Anne Hinks, Fraser Cummings, Noha Lim, Linda A. Bradbury, Rhian G. William, Nita G. Forouhi, Roberto Eluosa, Ingeleif B. Hallgrimsdottir, Giorgio Sirugo, Robert Luben, Veikko Salomaa, Robert Clarke, Sally John, Ursula Everson, Emma King, Ivan Nikolov, Heather M. Stringham, Antony P. Attwood, Angelo Scuteri, Wellcome Trust Case Control Consortium, Burton, PR., Clayton, DG., Cardon, LR., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, DP., McCarthy, MI., Ouwehand, WH., Samani, NJ., Todd, JA., Donnelly, P., Barrett, JC., Davison, D., Easton, D., Evans, D., Leung, HT., Marchini, JL., Morris, AP., Spencer, IC., Tobin, MD., Attwood, AP., Boorman, JP., Cant, B., Everson, U., Hussey, JM., Jolley, JD., Knight, AS., Koch, K., Meech, E., Nutland, S., Prowse, CV., Stevens, HE., Taylor, NC., Walters, GR., Walker, NM., Watkins, NA., Winzer, T., Jones, RW., McArdle, WL., Ring, SM., Strachan, DP., Pembrey, M., Breen, G., St Clair, D., Caesar, S., Gordon-Smith, K., Jones, L., Fraser, C., Green, EK., Grozeva, D., Hamshere, ML., Holmans, PA., Jones, IR., Kirov, G., Moskvina, V., Nikolov, I., O'Donovan, MC., Owen, MJ., Collier, DA., Elkin, A., Farmer, A., Williamson, R., McGuffin, P., Young, AH., Ferrier, IN., Ball, SG., Balmforth, AJ., Barrett, JH., Bishop, DT., Iles, MM., Maqbool, A., Yuldasheva, N., Hall, AS., Braund, PS., Dixon, RJ., Mangino, M., Stevens, S., Thompson, JR., Bredin, F., Tremelling, M., Parkes, M., Drummond, H., Lees, CW., Nimmo, ER., Satsangi, J., Fisher, SA., Forbes, A., Lewis, CM., Onnie, CM., Prescott, NJ., Sanderson, J., Mathew, CG., Barbour, J., Mohiuddin, MK., Todhunter, CE., Mansfield, JC., Ahmad, T., Cummings, FR., Jewell, DP., Webster, J., Brown, MJ., Lathrop, GM., Connell, J., Dominiczak, A., Braga Marcano, CA., Burke, B., Dobson, R., Gungadoo, J., Lee, KL., Munroe, PB., Newhouse, SJ., Onipinla, A., Wallace, I., Xue, M., Caulfield, M., Farrall, M., Barton, A., Bruce, IN., Donovan, H., Eyre, S., Gilbert, PD., Hider, SL., Hinks, AM., John, SL., Potter, C., Silman, AJ., Symmons, DP., Thomson, W., Worthington, J., Dunger, DB., Widmer, B., Frayling, TM., Freathy, RM., Lango, H., Perry, JR., Shields, BM., Weedon, MN., Hattersley, AT., Hitman, GA., Walker, M., Elliott, KS., Groves, CJ., Lindgren, CM., Rayner, NW., Timpson, NJ., Zeggini, E., Newport, M., Sirugo, G., Lyons, E., Vannberg, F., Hill, AV., Bradbury, LA., Farrar, C., Pointon, JJ., Wordsworth, P., Brown, MA., Franklyn, JA., Heward, JM., Simmonds, MJ., Gough, SC., Seal, S., Stratton, MR., Rahman, N., Ban, M., Goris, A., Sawcer, SJ., Compston, A., Conway, D., Jallow, M., Rockett, KA., Bryan, C., Bumpstead, SJ., Chaney, A., Downes, K., Ghori, J., Gwilliam, R., Hunt, SE., Inouye, M., Keniry, A., King, E., McGinnis, R., Potter, S., Ravindrarajah, R., Whittaker, P., Withers, D., Cardin, NJ., Ferreira, T., Pereira-Gale, J., Hallgrimsdóttir, IB., Howie, BN., Su, Z., Teo, YY., Vukcevic, D., Bentley, D., Life Course Epidemiology (LCE), Cardiovascular Centre (CVC), Lifestyle Medicine (LM), Groningen Kidney Center (GKC), Vascular Ageing Programme (VAP), and Medical Research Council (MRC)
- Subjects
Hemodynamics ,Genome-wide association study ,Blood Pressure ,030204 cardiovascular system & hematology ,0302 clinical medicine ,Diastole ,11 Medical and Health Sciences ,POPULATION ,Genetics ,Genetics & Heredity ,RISK ,0303 health sciences ,education.field_of_study ,Econometric and Statistical Methods: General ,CELL-DIFFERENTIATION ,biology ,Intracellular Signaling Peptides and Proteins ,Chromosome Mapping ,Steroid 17-alpha-Hydroxylase ,COMMON VARIANTS ,3. Good health ,DNA-Binding Proteins ,Europe ,Cardiovascular Diseases ,PUBLIC-HEALTH ,BARTTERS-SYNDROME ,Blood Pressure/genetics ,Cardiovascular Diseases/genetics ,Cardiovascular Diseases/physiopathology ,Cytochrome P-450 CYP1A2/genetics ,DNA-Binding Proteins/genetics ,Diastole/genetics ,European Continental Ancestry Group/genetics ,Fibroblast Growth Factor 5/genetics ,Genetic Variation ,Genome-Wide Association Study ,Humans ,India ,Methylenetetrahydrofolate Reductase (NADPH2)/genetics ,Open Reading Frames/genetics ,Phospholipase C delta/genetics ,Polymorphism, Single Nucleotide ,Proteins/genetics ,Steroid 17-alpha-Hydroxylase/genetics ,Systole/genetics ,Wellcome Trust Case Control Consortium ,Life Sciences & Biomedicine ,hypertension ,Fibroblast Growth Factor 5 ,Systole ,Population ,European Continental Ancestry Group ,METHYLENETETRAHYDROFOLATE REDUCTASE GENE ,Single-nucleotide polymorphism ,LOW-RENIN HYPERTENSION ,White People ,Article ,03 medical and health sciences ,Open Reading Frames ,Fibroblast growth factor-5 ,Cytochrome P-450 CYP1A2 ,Geneeskunde(GENK) ,education ,Methylenetetrahydrofolate Reductase (NADPH2) ,Adaptor Proteins, Signal Transducing ,030304 developmental biology ,Genetic association ,genome-wide association ,Science & Technology ,MUTATIONS ,Proteins ,06 Biological Sciences ,POLYMORPHISM ,Blood pressure ,Methylenetetrahydrofolate reductase ,biology.protein ,biology.gene ,Phospholipase C delta ,Developmental Biology - Abstract
Elevated blood pressure is a common, heritable cause of cardiovascular disease worldwide. To date, identification of common genetic variants influencing blood pressure has proven challenging. We tested 2.5 million genotyped and imputed SNPs for association with systolic and diastolic blood pressure in 34,433 subjects of European ancestry from the Global BPgen consortium and followed up findings with direct genotyping (N ≤ 71,225 European ancestry, N ≤ 12,889 Indian Asian ancestry) and in silico comparison (CHARGE consortium, N = 29,136). We identified association between systolic or diastolic blood pressure and common variants in eight regions near the CYP17A1 (P = 7 × 10(-24)), CYP1A2 (P = 1 × 10(-23)), FGF5 (P = 1 × 10(-21)), SH2B3 (P = 3 × 10(-18)), MTHFR (P = 2 × 10(-13)), c10orf107 (P = 1 × 10(-9)), ZNF652 (P = 5 × 10(-9)) and PLCD3 (P = 1 × 10(-8)) genes. All variants associated with continuous blood pressure were associated with dichotomous hypertension. These associations between common variants and blood pressure and hypertension offer mechanistic insights into the regulation of blood pressure and may point to novel targets for interventions to prevent cardiovascular disease.
- Published
- 2009
- Full Text
- View/download PDF
165. The effect of elevated carbon dioxide on the interaction between <scp>E</scp> ucalyptus grandis and diverse isolates of <scp>P</scp> isolithus sp. is associated with a complex shift in the root transcriptome
- Author
-
Krista L. Plett, Ian C. Anderson, Jonathan M. Plett, Annegret Kohler, Amit N. Khachane, Kerry L Keniry, and Francis Martin
- Subjects
Mutualism (biology) ,biology ,Physiology ,Plant Science ,15. Life on land ,biology.organism_classification ,Pisolithus ,Eucalyptus ,Transcriptome ,13. Climate action ,Phylogenetics ,Botany ,Gene expression ,Colonization ,Internal transcribed spacer - Abstract
Using the newly available genome for Eucalyptus grandis, we sought to determine the genome-wide traits that enable this host to form mutualistic interactions with ectomycorrhizal (ECM) Pisolithus sp. and to determine how future predicted concentrations of atmospheric carbon dioxide (CO2 ) will affect this relationship. We analyzed the physiological and transcriptomic responses of E. grandis during colonization by different Pisolithus sp. isolates under conditions of ambient (400 ppm) and elevated (650 ppm) CO2 to tease out the gene expression profiles associated with colonization status. We demonstrate that E. grandis varies in its susceptibility to colonization by different Pisolithus isolates in a manner that is not predictable by geographic origin or the internal transcribed spacer (ITS)-based phylogeny of the fungal partner. Elevated concentrations of CO2 alter the receptivity of E. grandis to Pisolithus, a change that is correlated to a dramatic shift in the transcriptomic profile of the root. These data provide a starting point for understanding how future environmental change may alter the signaling between plants and their ECM partners and is a step towards determining the mechanism behind previously observed shifts in Eucalypt-associated fungal communities exposed to elevated concentrations of atmospheric CO2 .
- Published
- 2014
- Full Text
- View/download PDF
166. Metformin and erlotinib synergize to inhibit basal breast cancer
- Author
-
Ying-Ka Ingar Lau, Tiffany Thomas, Xing Du, Jacquelyn Shaw, Benjamin D. Hopkins, Maira M. Pires, Matthias Szabolcs, Matthew A. Maurer, Megan Keniry, Vinayak Rayannavar, Ramon Parsons, Serge Cremers, and Eliana Bessler
- Subjects
erlotinib ,PTEN ,Apoptosis ,Immunoenzyme Techniques ,Mice ,Phosphatidylinositol 3-Kinases ,0302 clinical medicine ,Antineoplastic Combined Chemotherapy Protocols ,Tumor Cells, Cultured ,Phosphorylation ,Erlotinib Hydrochloride ,EGFR inhibitors ,0303 health sciences ,Drug Synergism ,Flow Cytometry ,Metformin ,3. Good health ,ErbB Receptors ,Oncology ,030220 oncology & carcinogenesis ,Female ,Erlotinib ,medicine.drug ,Research Paper ,Signal Transduction ,EGFR ,Blotting, Western ,Breast Neoplasms ,Biology ,03 medical and health sciences ,breast cancer ,medicine ,Biomarkers, Tumor ,Animals ,Humans ,Hypoglycemic Agents ,Protein kinase B ,Protein Kinase Inhibitors ,030304 developmental biology ,Cell Proliferation ,Cell growth ,PTEN Phosphohydrolase ,Xenograft Model Antitumor Assays ,Cancer research ,biology.protein ,Quinazolines ,Proto-Oncogene Proteins c-akt - Abstract
Basal-like breast cancers (BBCs) are enriched for increased EGFR expression and decreased expression of PTEN. We found that treatment with metformin and erlotinib synergistically induced apoptosis in a subset of BBC cell lines. The drug combination led to enhanced reduction of EGFR, AKT, S6 and 4EBP1 phosphorylation, as well as prevented colony formation and inhibited mammosphere outgrowth. Our data with other compounds suggested that biguanides combined with EGFR inhibitors have the potential to outperform other targeted drug combinations and could be employed in other breast cancer subtypes, as well as other tumor types, with activated EGFR and PI3K signaling. Analysis of BBC cell line alterations led to the hypothesis that loss of PTEN sensitized cells to the drug combination which was confirmed using isogenic cell line models with and without PTEN expression. Combined metformin and erlotinib led to partial regression of PTEN-null and EGFR-amplified xenografted MDA-MB-468 BBC tumors with evidence of significant apoptosis, reduction of EGFR and AKT signaling, and lack of altered plasma insulin levels. Combined treatment also inhibited xenografted PTEN null HCC-70 BBC cells. Measurement of trough plasma drug levels in xenografted mice and a separately performed pharmacokinetics modeling study support possible clinical translation.
- Published
- 2014
167. Coadsorption of Low-Molecular Weight Aromatic and Aliphatic Alcohols and Acids with the Cationic Surfactant, CTAB, on Silica Surfaces
- Author
-
Vincent S. J. Craig, Max A. Keniry, Guangming Liu, and Thipvaree Wangchareansak
- Subjects
chemistry.chemical_classification ,Double bond ,Chemistry ,Inorganic chemistry ,Intermolecular force ,Cationic polymerization ,Surfaces and Interfaces ,Condensed Matter Physics ,Photochemistry ,Micelle ,Isophthalic acid ,chemistry.chemical_compound ,Adsorption ,Pulmonary surfactant ,Electrochemistry ,Molecule ,General Materials Science ,Spectroscopy - Abstract
We have investigated the coadsorption of a range of small molecules with the cationic surfactant CTAB to silica surfaces over a range of concentrations and CTAB to solute ratios and compared the coadsorption with adsorption in the presence of the salicylate ion. We find that molecules with aromatic character and molecules with double bonds are most favorably adsorbed, and we attribute this to cation-π bonding between the surfactant headgroups and the π orbitals of the unsaturated bonds of the solute molecules. The adsorption is complex and depends on chemical interactions between the solute molecules and the surfactant, which are highly specific to the structure of the solute. To improve our understanding of the specifics of these interactions, we have performed one-dimensional rotating frame Overhauser spectroscopy (ROESY) nuclear magnetic resonance experiments. These experiments show the complexity of the intermolecular interactions and can be used to determine the position of the solute molecule with regard to the CTAB molecules in the adsorbed aggregates. The ROESY spectrum for the salicylate anion is distinct from those of the other solute molecules and suggests that the anions are dimerizing. Along with the cation-π bonding between the dimers, this provides a model for the strong influence that salicylate has on adsorption, micellar structure, and viscoelasticity. The ROESY data indicate that the catechol molecule interacts with all parts of the surfactant alkane chains such that they wrap around the molecule, but this has little effect on the interfacial curvature or aggregate shape. More intense isophthalic acid-CTAB intermolecular ROEs compared to those of other aromatic solutes are consistent with an interaction between isophthalic acid and the headgroups of two surfactant molecules that slows the intramicellar motion of isophthalic acid. Differences in interactions between solute molecules and the aliphatic surfactant chains do not result in changes in micelle structure.
- Published
- 2014
- Full Text
- View/download PDF
168. The flanking sequence contributes to the immobilisation of spermine at the G-quadruplex in the NHE (nuclease hypersensitivity element) III1of the c-Mycpromoter
- Author
-
Max A. Keniry and Elisabeth A. Owen
- Subjects
Models, Molecular ,Conformational change ,Magnetic Resonance Spectroscopy ,Protein Conformation ,Base pair ,Oligonucleotides ,Biophysics ,Spermine ,G-quadruplex ,Biochemistry ,Proto-Oncogene Proteins c-myc ,chemistry.chemical_compound ,NMR spectroscopy ,Quadruplex DNA ,Structural Biology ,Gene expression ,Genetics ,heterocyclic compounds ,Nucleotide ,c-Myc regulation ,Promoter Regions, Genetic ,Molecular Biology ,chemistry.chemical_classification ,DNA recognition ,Nuclease ,biology ,Chemistry ,Circular Dichroism ,Cell Biology ,Polyamine binding ,Molecular biology ,G-Quadruplexes ,Gene Expression Regulation ,Mutation ,biology.protein ,Protein Binding - Abstract
Defining the molecular basis of the DNA sequence selectivity of polyamine binding is central to understanding polyamine-dependent gene expression. We have studied, by selective NMR experiments, the variation of spermine mobility and conformation in the presence of G-quadruplexes formed by sequences of the purine-rich strand of the c-Myc promoter, nuclease hypersensitivity element III1 (NHE III1). All the NHE quadruplexes restrict spermine mobility and induce a spermine conformational change but the most effective immobilisation occurs when all five G-tracts of the NHE III1 are present. This suggests structure within the nucleotides flanking the G-quadruplex has a role in immobilising spermine.
- Published
- 2014
- Full Text
- View/download PDF
169. Solution Structure and Backbone Dynamics of Long-[Arg3]insulin-like Growth Factor-I
- Author
-
Laajoki, Leanne G., Francis, Geoffrey L., Wallace, John C., Carver, John A., and Keniry, Max A.
- Published
- 2000
- Full Text
- View/download PDF
170. Using long-read sequencing to detect imprinted DNA methylation
- Author
-
Gigante, Scott, primary, Gouil, Quentin, additional, Lucattini, Alexis, additional, Keniry, Andrew, additional, Beck, Tamara, additional, Tinning, Matthew, additional, Gordon, Lavinia, additional, Woodruff, Chris, additional, Speed, Terence P., additional, Blewitt, Marnie E., additional, and Ritchie, Matthew E., additional
- Published
- 2018
- Full Text
- View/download PDF
171. Long-range chromatin interactions on the inactive X and atHoxclusters are regulated by the non-canonical SMC protein Smchd1
- Author
-
Jansz, Natasha, primary, Keniry, Andrew, additional, Trussart, Marie, additional, Bildsoe, Heidi, additional, Beck, Tamara, additional, Tonks, Ian D., additional, Mould, Arne W., additional, Hickey, Peter, additional, Breslin, Kelsey, additional, Iminitoff, Megan, additional, Ritchie, Matthew E., additional, McGlinn, Edwina, additional, Kay, Graham F., additional, Murphy, James M., additional, and Blewitt, Marnie E., additional
- Published
- 2018
- Full Text
- View/download PDF
172. Studying X chromosome inactivation in the single-cell genomic era
- Author
-
Keniry, Andrew, primary and Blewitt, Marnie E., additional
- Published
- 2018
- Full Text
- View/download PDF
173. FOXO Transcription Factors Rewire Metabolism in U87MG Glioblastoma Cells
- Author
-
Keniry, Megan, primary, Fanniel, Victor, additional, Martinez, Eduardo, additional, Sanchez, Lilia, additional, Vazquez, Neftali, additional, Lopez, Alma, additional, Cedillo, Raechel, additional, Respondek, Christa, additional, Gilkerson, Robert, additional, Innis‐Whitehouse, Wendy, additional, and Scheunzel, Erin, additional
- Published
- 2018
- Full Text
- View/download PDF
174. Genetic Dissection of PTEN Signaling Mechanisms in Prostate Cancer
- Author
-
Keniry, Megan E., primary, Hannon, Greg, primary, and Parsons, Ramon, primary
- Published
- 2005
- Full Text
- View/download PDF
175. Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis
- Author
-
Cindy Hodakoski, Ramon Parsons, Phillip T. Hawkins, Douglas Barrows, Megan Keniry, Sarah M. Mense, Benjamin D. Hopkins, Karen E. Anderson, Philip A. Kern, and Len R. Stephens
- Subjects
Male ,Gene Expression Regulation, Enzymologic ,Mice ,chemistry.chemical_compound ,Insulin resistance ,Catalytic Domain ,medicine ,Homeostasis ,Animals ,Guanine Nucleotide Exchange Factors ,Humans ,Insulin ,Tensin ,Glucose homeostasis ,PTEN ,Phosphatidylinositol ,Phosphorylation ,PI3K/AKT/mTOR pathway ,Cell Proliferation ,Mice, Knockout ,Binding Sites ,Multidisciplinary ,biology ,GTPase-Activating Proteins ,PTEN Phosphohydrolase ,Blood Proteins ,Biological Sciences ,Fibroblasts ,Phosphoproteins ,medicine.disease ,Cell biology ,Mice, Inbred C57BL ,Pleckstrin homology domain ,Insulin receptor ,Glucose ,HEK293 Cells ,chemistry ,Cancer research ,biology.protein ,Insulin Resistance ,Protein Binding - Abstract
Insulin activation of phosphoinositide 3-kinase (PI3K) signaling regulates glucose homeostasis through the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3). The dual-specificity phosphatase and tensin homolog deleted on chromosome 10 (PTEN) blocks PI3K signaling by dephosphorylating PIP3, and is inhibited through its interaction with phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 (P-REX2). The mechanism of inhibition and its physiological significance are not known. Here, we report that P-REX2 interacts with PTEN via two interfaces. The pleckstrin homology (PH) domain of P-REX2 inhibits PTEN by interacting with the catalytic region of PTEN, and the inositol polyphosphate 4-phosphatase domain of P-REX2 provides high-affinity binding to the postsynaptic density-95/Discs large/zona occludens-1-binding domain of PTEN. P-REX2 inhibition of PTEN requires C-terminal phosphorylation of PTEN to release the P-REX2 PH domain from its neighboring diffuse B-cell lymphoma homology domain. Consistent with its function as a PTEN inhibitor, deletion of Prex2 in fibroblasts and mice results in increased Pten activity and decreased insulin signaling in liver and adipose tissue. Prex2 deletion also leads to reduced glucose uptake and insulin resistance. In human adipose tissue, P-REX2 protein expression is decreased and PTEN activity is increased in insulin-resistant human subjects. Taken together, these results indicate a functional role for P-REX2 PH-domain-mediated inhibition of PTEN in regulating insulin sensitivity and glucose homeostasis and suggest that loss of P-REX2 expression may cause insulin resistance.
- Published
- 2013
- Full Text
- View/download PDF
176. Insight into the molecular recognition of spermine by DNA quadruplexes from an NMR study of the association of spermine with the thrombin-binding aptamer
- Author
-
Elisabeth A. Owen and Max A. Keniry
- Subjects
education.field_of_study ,Stereochemistry ,Chemistry ,Hydrogen bond ,Aptamer ,Population ,Spermine ,Nuclear magnetic resonance spectroscopy ,Nuclear Overhauser effect ,G-quadruplex ,chemistry.chemical_compound ,Molecular recognition ,Structural Biology ,education ,Molecular Biology - Abstract
The preferred residence sites and the conformation of DNA-bound polyamines are central to understanding the regulatory roles of polyamines. To this end, we have used a series of selective 13C-edited and selective total correlation spectroscopy-edited one-dimensional (1D) nuclear Overhauser effect spectroscopy NMR experiments to determine a number of intramolecular 1H nuclear Overhauser effect (NOE) connectivities in 13C-labelled spermine bound to the thrombin-binding aptamer. The results provide evidence that the aptamer-bound spermine adopts a conformation that optimizes electrostatic and hydrogen bond contacts with the aptamer backbone. The distance between the nitrogen atoms of the central aminobutyl is reduced by an increase in the population of gauche conformers at the C6–C7 bonds, which results in either a curved or S-shaped spermine conformation. Molecular modelling contributes insight toward the mode of spermine binding of these spermine structures within the narrow grooves of DNA quadruplexes. In each case, the N5 ammonium group makes hydrogen bonds with two nearby phosphates across the narrow groove. Our results have implications for the understanding of chromatin structure and the rational design of quadruplex-binding drugs. Copyright © 2013 John Wiley & Sons, Ltd.
- Published
- 2013
- Full Text
- View/download PDF
177. Survival factor NFIL3 restricts FOXO-induced gene expression in cancer
- Author
-
Ashley Calahan, Andrea Califano, Ben Hopkins, Ying Ka Ingar Lau, Susan Koujak, Matt Maurer, Ronald A. DePinho, Sarah M. Mense, Ramon Parsons, Megan Keniry, Celine Lefebvre, Karen Justiano, Boyi Gan, Franklyn Fenton, Joseph Toole, Maira M. Pires, and Cindy Hodakoski
- Subjects
Programmed cell death ,Apoptosis ,Breast Neoplasms ,FOXO1 ,Kaplan-Meier Estimate ,Histone Deacetylases ,TNF-Related Apoptosis-Inducing Ligand ,Cell Line, Tumor ,Genetics ,Humans ,RNA, Small Interfering ,Promoter Regions, Genetic ,Transcription factor ,Regulation of gene expression ,Binding Sites ,biology ,Forkhead Box Protein O1 ,NFIL3 ,Forkhead Transcription Factors ,Prognosis ,Chromatin ,Gene Expression Regulation, Neoplastic ,Basic-Leucine Zipper Transcription Factors ,HEK293 Cells ,Histone ,Cancer research ,biology.protein ,FOXO3 ,Protein Binding ,Research Paper ,Developmental Biology - Abstract
Depending on the circumstance, FOXO (Forkhead O) (FOXO1, FOXO3, and FOXO4) transcription factors activate the expression of markedly different sets of genes to produce different phenotypic effects. For example, distinct FOXO-regulated transcriptional programs stimulate cell death or enhance organism life span. To gain insight into how FOXOs select specific genes for regulation, we performed a screen for genes that modify FOXO activation of TRAIL, a death receptor ligand capable of inducing extrinsic apoptosis. We discovered that the bZIP transcriptional repressor NFIL3 (nuclear factor interleukin 3-regulated) hindered FOXO transcription factor access to chromatin at the TRAIL promoter by binding to nearby DNA and recruiting histone deacetylase-2 (HDAC2) to reduce histone acetylation. In the same manner, NFIL3 repressed expression of certain FOXO targets—e.g., FAS, GADD45α (growth arrest and DNA damage-inducible, α), and GADD45β—but not others. NFIL3, which we found to be overexpressed in different cancers, supported tumor cell survival largely through repression of TRAIL and antagonized hydrogen peroxide-induced cell death. Moreover, its expression in cancer was associated with lower patient survival. Therefore, NFIL3 alters cancer cell behavior and FOXO function by acting on chromatin to restrict the menu of FOXO target genes. Targeting of NFIL3 could be of therapeutic benefit for cancer patients.
- Published
- 2013
- Full Text
- View/download PDF
178. Reducing Anode Carbon Consumption in Smelting Cells
- Author
-
Chemeca 88 (16th : 1988 : Sydney, N.S.W.), Fitchett, AM, Welch, BJ, Keniry, JT, and Sadler, BA
- Published
- 1988
179. Energy from Biomass
- Author
-
Prince, RGH, Barford, JP, Barrett, D, Brooks, RB, Gorrie, I, Greenfield, PF, Keniry, JS, Kirby, KD, Lane, AG, Prince, IG, Ralph, BJ, Rickard, PAD, Stewart, GA, and Wonder, B
- Published
- 1983
180. Can Nanopore Sequencing Change Cancer Diagnostics
- Author
-
Woodruff, Chris, Gigante, Scott, Lucattini, Alexis, Keniry, Andrew, Ritchie, Matt, and Speed, Terry
- Published
- 2017
- Full Text
- View/download PDF
181. Il-23r is a major determinant of ankylosing spondylitis risk - The tasc study
- Author
-
Reveille, JD, Zhou, X, Bradbury, LA, Cardon, LR, Davis, JC, Deloukas, P, Evans, DM, Keniry, A, McGinnis, R, Pointon, J, Ward, MM, Weisman, MH, Wordsworth, P, and Brown, MA
- Published
- 2016
182. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
- Author
-
Burton, PR, Clayton, DG, Cardon, LR, Craddock, N, Deloukas, P, Duncanson, A, Kwiatkowski, DP, McCarthy, MI, Ouwehand, WH, Samani, NJ, Todd, JA, Donnelly, P, Barrett, JC, Davison, D, Easton, D, Evans, DM, Leung, HT, Marchini, JL, Morris, AP, Spencer, CC, Tobin, MD, Attwood, AP, Boorman, JP, Cant, B, Everson, U, Hussey, JM, Jolley, JD, Knight, AS, Koch, K, Meech, E, Nutland, S, Prowse, CV, Stevens, HE, Taylor, NC, Walters, GR, Walker, NM, Watkins, NA, Winzer, T, Jones, RW, McArdle, WL, Ring, SM, Strachan, DP, Pembrey, M, Breen, G, St Clair, D, Caesar, S, Gordon-Smith, K, Jones, L, Fraser, C, Green, EK, Grozeva, D, Hamshere, ML, Holmans, PA, Jones, IR, Kirov, G, Moskivina, V, Nikolov, I, O'Donovan, MC, Owen, MJ, Collier, DA, Elkin, A, Farmer, A, Williamson, R, McGuffin, P, Young, AH, Ferrier, IN, Ball, SG, Balmforth, AJ, Barrett, JH, Bishop, TD, Iles, MM, Maqbool, A, Yuldasheva, N, Hall, AS, Braund, PS, Dixon, RJ, Mangino, M, Stevens, S, Thompson, JR, Bredin, F, Tremelling, M, Parkes, M, Drummond, H, Lees, CW, Nimmo, ER, Satsangi, J, Fisher, SA, Forbes, A, Lewis, CM, Onnie, CM, Prescott, NJ, Sanderson, J, Matthew, CG, Barbour, J, Mohiuddin, MK, Todhunter, CE, Mansfield, JC, Ahmad, T, Cummings, FR, Jewell, DP, Webster, J, Brown, MJ, Lathrop, MG, Connell, J, Dominiczak, A, Marcano, CA, Burke, B, Dobson, R, Gungadoo, J, Lee, KL, Munroe, PB, Newhouse, SJ, Onipinla, A, Wallace, C, Xue, M, Caulfield, M, Farrall, M, Barton, A, Bruce, IN, Donovan, H, Eyre, S, Gilbert, PD, Hilder, SL, Hinks, AM, John, SL, Potter, C, Silman, AJ, Symmons, DP, Thomson, W, Worthington, J, Dunger, DB, Widmer, B, Frayling, TM, Freathy, RM, Lango, H, Perry, JR, Shields, BM, Weedon, MN, Hattersley, AT, Hitman, GA, Walker, M, Elliott, KS, Groves, CJ, Lindgren, CM, Rayner, NW, Timpson, NJ, Zeggini, E, Newport, M, Sirugo, G, Lyons, E, Vannberg, F, Hill, AV, Bradbury, LA, Farrar, C, Pointon, JJ, Wordsworth, P, Brown, MA, Franklyn, JA, Heward, JM, Simmonds, MJ, Gough, SC, Seal, S, Stratton, MR, Rahman, N, Ban, M, Goris, A, Sawcer, SJ, Compston, A, Conway, D, Jallow, M, Rockett, KA, Bumpstead, SJ, Chaney, A, Downes, K, Ghori, MJ, Gwilliam, R, Hunt, SE, Inouye, M, Keniry, A, King, E, McGinnis, R, Potter, S, Ravindrarajah, R, Whittaker, P, Widden, C, Withers, D, Cardin, NJ, Ferreira, T, Pereira-Gale, J, Hallgrimsdo'ttir, IB, Howie, BN, Su, Z, Teo, YY, Vukcevic, D, Bentley, D, Mitchell, SL, Newby, PR, Brand, OJ, Carr-Smith, J, Pearce, SH, Reveille, JD, Zhou, X, Sims, AM, Dowling, A, Taylor, J, Doan, T, Davis, JC, Savage, L, Ward, MM, Learch, TL, Weisman, MH, and Brown, M
- Subjects
Linkage disequilibrium ,Multiple Sclerosis ,Genotype ,Population ,Single-nucleotide polymorphism ,Genome-wide association study ,Autoimmunity ,Breast Neoplasms ,Biology ,medicine.disease_cause ,Aminopeptidases ,Polymerase Chain Reaction ,Polymorphism, Single Nucleotide ,Linkage Disequilibrium ,Article ,Minor Histocompatibility Antigens ,Genetics ,medicine ,Humans ,Spondylitis, Ankylosing ,Receptors, Immunologic ,education ,Genetic association ,education.field_of_study ,Ankylosing spondylitis ,Thyroiditis, Autoimmune ,Chromosome Mapping ,Receptors, Interleukin ,medicine.disease ,Endoplasmic reticulum aminopeptidase 2 ,Genetics, Population ,Haplotypes ,Case-Control Studies ,Immunology ,North America - Abstract
We have genotyped 14,436 nonsynonymous SNPs (nsSNPs) and 897 major histocompatibility complex (MHC) tag SNPs from 1,000 independent cases of ankylosing spondylitis (AS), autoimmune thyroid disease (AITD), multiple sclerosis (MS) and breast cancer (BC). Comparing these data against a common control dataset derived from 1,500 randomly selected healthy British individuals, we report initial association and independent replication in a North American sample of two new loci related to ankylosing spondylitis, ARTS1 and IL23R, and confirmation of the previously reported association of AITD with TSHR and FCRL3. These findings, enabled in part by increased statistical power resulting from the expansion of the control reference group to include individuals from the other disease groups, highlight notable new possibilities for autoimmune regulation and suggest that IL23R may be a common susceptibility factor for the major 'seronegative' diseases.
- Published
- 2016
- Full Text
- View/download PDF
183. Discovery and Analysis of Natural-Product Compounds Inhibiting Protein Synthesis in Pseudomonas aeruginosa
- Author
-
Stephanie O. Palmer, James M. Bullard, Yanmei Hu, and Megan Keniry
- Subjects
0301 basic medicine ,medicine.disease_cause ,Gram-Positive Bacteria ,Enterococcus faecalis ,Microbiology ,Cell Line ,03 medical and health sciences ,chemistry.chemical_compound ,Inhibitory Concentration 50 ,0302 clinical medicine ,Bacterial Proteins ,medicine ,Protein biosynthesis ,Humans ,Pharmacology (medical) ,Pseudomonas Infections ,Escherichia coli ,Pharmacology ,chemistry.chemical_classification ,Analytical Procedures ,Biological Products ,Natural product ,biology ,Pseudomonas aeruginosa ,biology.organism_classification ,Amino acid ,Anti-Bacterial Agents ,030104 developmental biology ,Infectious Diseases ,HEK293 Cells ,chemistry ,Staphylococcus aureus ,030220 oncology & carcinogenesis ,Protein Biosynthesis ,Ribosomes ,Bacteria - Abstract
Bacterial protein synthesis is the target for numerous natural and synthetic antibacterial agents. We have developed a poly(U) mRNA-directed aminoacylation/translation (A/T) protein synthesis system composed of phenylalanyl-tRNA synthetases (PheRS), ribosomes, and ribosomal factors from Pseudomonas aeruginosa . This system has been used for high-throughput screening of a natural-compound library. Assays were developed for each component of the system to ascertain the specific target of inhibitory compounds. In high-throughput screens, 13 compounds were identified that inhibit protein synthesis with 50% inhibitory concentrations ranging from 0.3 to >80 μM. MICs were determined for the compounds against the growth of a panel of pathogenic organisms, including Enterococcus faecalis , Escherichia coli , Haemophilus influenzae , Moraxella catarrhalis , P. aeruginosa , Staphylococcus aureus , and Streptococcus pneumoniae . Three of the compounds were observed to have broad-spectrum activity and inhibited a hypersensitive strain of P. aeruginosa with MICs of 8 to 16 μg/ml. The molecular target of each of the three compounds was determined to be PheRS. One compound was found to be bacteriostatic, and one compound was bactericidal against both Gram-positive and Gram-negative pathogens. The third compound was observed to be bacteriostatic against Gram-positive and bactericidal against Gram-negative bacteria. All three compounds were competitive with the substrate ATP; however, one compound was competitive, one was uncompetitive, and one noncompetitive with the amino acid substrate. Macromolecular synthesis assays confirm the compounds inhibit protein synthesis. The compounds were shown to be more than 25,000-fold less active than the control staurosporine in cytotoxicity MTT testing in human cell lines.
- Published
- 2016
184. Seasonal Flow Rates along the Lower Bear River, UT
- Author
-
Keniry, Todd, Curiel, Dahlia, Anderson, Dylan, Alafifi, Ayman, and Rosenberg, David E.
- Subjects
Environmental Engineering ,Earth Sciences ,Life Sciences ,Hydraulic Engineering ,Environmental Sciences - Abstract
The goal of this research is to identify how flow on the Bear River in Cache Valley has changed over the last three years and how flow changes seasonally. Identifying flows is important to manage water resources along the Bear River. We collected and processed water pressure data every 30 minutes using HOBO transducers at two sites in Cache Valley (Morton, just downstream of highway 142, and Confluence which is located at the confluence of the Bear and Cub Rivers) south of the Idaho‐Utah border in 2015. We also measured flow and water stage up to three times per year at each site using an Acoustic Doppler Current profiler and transom survey equipment. We pooled these observations with measurements and data collected by prior undergraduate Bear River Fellow researchers in 2012 and 2013 and used the observations to generate linear regression models to relate water stage to flow at each site. By applying the linear regression model to our pressure measurements, we calculated flow at each time a pressure reading was recorded for its respective location on the lower Bear River. We used the flow rates to determine that very little water is lost or gained between the USGS gage and the Morton site but that during summer months nearly 300cfs is lost between the Morton and Confluence sites. This information can help Bear River pumpers better manage their use.
- Published
- 2016
185. Co-polymerization analysis of thermosetting resins using1H-15N-13C triple resonance NMR spectroscopy
- Author
-
Melissa J. Latter, Max A. Keniry, Christopher J. Easton, Amy Philbrook, and Scott Earnshaw
- Subjects
chemistry.chemical_classification ,Materials science ,Polymers and Plastics ,Urea-formaldehyde ,Thermosetting polymer ,General Chemistry ,Nuclear magnetic resonance spectroscopy ,Polymer ,Surfaces, Coatings and Films ,chemistry.chemical_compound ,chemistry ,Polymerization ,Materials Chemistry ,Copolymer ,Organic chemistry ,Adhesive ,Spectroscopy ,Nuclear chemistry - Abstract
1H-15N-13C correlation NMR spectroscopy techniques developed to identify and characterize co-polymer fragments in melamine-urea-formaldehyde (MUF) and phenol-urea-formaldehyde (PUF) model systems have been applied to industrially prepared MUF, PUF, and phenol-melamine-formaldehyde (PMF) resins. The NMR data confirm that co-polymers form in a commercially prepared MUF resin manufactured by Momentive Specialty Chemicals Pty. Ltd. Spectra from PUF model reactions were compared with those from a PUF resin and it was determined that PUF co-polymers did not form in the resin prepared using typical temperature and pH. Finally, NMR spectroscopy was used to identify and characterize PMF co-polymer bonds in a phenol-melamine-urea-formaldehyde (PMUF) resin prepared using a procedure from Momentive Specialty Chemicals Pty. Ltd. With these NMR techniques in hand, it is now possible to relate co-polymer structures to properties of commercial thermosets. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013
- Published
- 2012
- Full Text
- View/download PDF
186. The H19 lincRNA is a developmental reservoir of miR-675 which suppresses growth and Igf1r
- Author
-
Andrew Keniry, Paul Monnier, David Oxley, Michael Kyba, Guillaume Smits, Luisa Dandolo, and Wolf Reik
- Subjects
Ribonuclease III ,RNA, Untranslated ,Time Factors ,medicine.medical_treatment ,Placenta ,Receptor, IGF Type 1 ,DEAD-box RNA Helicases ,Exon ,Mice ,0302 clinical medicine ,RNA interference ,Pregnancy ,Mice, Knockout ,0303 health sciences ,Gene Expression Regulation, Developmental ,Exons ,female genital diseases and pregnancy complications ,Cell biology ,medicine.anatomical_structure ,ELAV Proteins ,030220 oncology & carcinogenesis ,embryonic structures ,Female ,RNA Interference ,RNA, Long Noncoding ,Signal transduction ,Signal Transduction ,Down-Regulation ,Gestational Age ,Mice, Transgenic ,Biology ,Transfection ,Article ,Cell Line ,03 medical and health sciences ,microRNA ,medicine ,Animals ,030304 developmental biology ,Insulin-like growth factor 1 receptor ,Cell Proliferation ,Cell growth ,Growth factor ,Cell Biology ,Molecular biology ,Placentation ,Mice, Inbred C57BL ,MicroRNAs ,Mice, Inbred CBA - Abstract
The H19 large intergenic non-coding RNA (lincRNA) is one of the most highly abundant and conserved transcripts in mammalian development, being expressed in both embryonic and extra-embryonic cell lineages, yet its physiological function is unknown. Here we show that miR-675, a microRNA (miRNA) embedded in H19's first exon, is expressed exclusively in the placenta from the gestational time point when placental growth normally ceases, and placentas that lack H19 continue to grow. Overexpression of miR-675 in a range of embryonic and extra-embryonic cell lines results in their reduced proliferation; targets of the miRNA are upregulated in the H19 null placenta, including the growth-promoting insulin-like growth factor 1 receptor (Igf1r) gene. Moreover, the excision of miR-675 from H19 is dynamically regulated by the stress-response RNA-binding protein HuR. These results suggest that H19's main physiological role is in limiting growth of the placenta before birth, by regulated processing of miR-675. The controlled release of miR-675 from H19 may also allow rapid inhibition of cell proliferation in response to cellular stress or oncogenic signals.
- Published
- 2012
187. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
- Author
-
Nejentsev, Sergey, Howson, Joanna M. M., Walker, Neil M., Szeszko, Jeffrey, Field, Sarah F., Stevens, Helen E., Reynolds, Pamela, Hardy, Matthew, King, Erna, Masters, Jennifer, Hulme, John, Maier, Lisa M., Smyth, Deborah, Bailey, Rebecca, Cooper, Jason D., Ribas, Gloria, Campbell, R. Duncan, Clayton, David G., Todd, John A., Burton, Paul R., Cardon, Lon R., Craddock, Nick, Deloukas, Panos, Duncanson, Audrey, Kwiatkowski, Dominic P., McCarthy, Mark I., Ouwehand, Willem H., Samani, Nilesh J., Donnelly, Peter, Barrett, Jeffrey C., Davison, Dan, Easton, Doug, Evans, David, Leung, Hin-Tak, Marchini, Jonathan L., Morris, Andrew P., Spencer, Chris C. A., Tobin, Martin D., Attwood, Antony P., Boorman, James P., Cant, Barbara, Everson, Ursula, Hussey, Judith M., Jolley, Jennifer D., Knight, Alexandra S., Koch, Kerstin, Meech, Elizabeth, Nutland, Sarah, Prowse, Christopher V., Taylor, Niall C., Walters, Graham R., Watkins, Nicholas A., Winzer, Thilo, Jones, Richard W., McArdle, Wendy L., Ring, Susan M., Strachan, David P., Pembrey, Marcus, Breen, Gerome, St Clair, David, Caesar, Sian, Gordon-Smith, Katherine, Jones, Lisa, Fraser, Christine, Green, Elaine K., Grozeva, Detelina, Hamshere, Marian L., Holmans, Peter A., Jones, Ian R., Kirov, George, Moskvina, Valentina, Nikolov, Ivan, O'Donovan, Michael C., Owen, Michael J., Collier, David A., Elkin, Amanda, Farmer, Anne, Williamson, Richard, McGuffin, Peter, Young, Allan H., Nicol Ferrier, I., Ball, Stephen G., Balmforth, Anthony J., Barrett, Jennifer H., Bishop, D. Timothy, Iles, Mark M., Maqbool, Azhar, Yuldasheva, Nadira, Hall, Alistair S., Braund, Peter S., Dixon, Richard J., Mangino, Massimo, Stevens, Suzanne, Thompson, John R., Bredin, Francesca, Tremelling, Mark, Parkes, Miles, Drummond, Hazel, Lees, Charles W., Nimmo, Elaine R., Satsangi, Jack, Fisher, Sheila A., Forbes, Alastair, Lewis, Cathryn M., Onnie, Clive M., Prescott, Natalie J., Sanderson, Jeremy, Mathew, Christopher G., Barbour, Jamie, Khalid Mohiuddin, M., Todhunter, Catherine E., Mansfield, John C., Ahmad, Tariq, Cummings, Fraser R., Jewell, Derek P., Webster, John, Brown, Morris J., Lathrop, G. Mark, Connell, John, Dominiczak, Anna, Braga, Carolina A., Burke, Beverley, Dobson, Richard, Gungadoo, Johannie, Lee, Kate L., Munroe, Patricia B., Newhouse, Stephen J., Onipinla, Abiodun, Wallace, Chris, Xue, Mingzhan, Caulfield, Mark, Farrall, Martin, Barton, Anne, Bruce, Ian N., Donovan, Hannah, Eyre, Steve, Gilbert, Paul D., Hider, Samantha L., Hinks, Anne M., John, Sally L., Potter, Catherine, Silman, Alan J., Symmons, Deborah P. M., Thomson, Wendy, Worthington, Jane, Dunger, David B., Widmer, Barry, Frayling, Timothy M., Freathy, Rachel M., Lango, Hana, Perry, John R. B., Shields, Beverley M., Weedon, Michael N., Hattersley, Andrew T., Hitman, Graham A., Walker, Mark, Elliott, Kate S., Groves, Christopher J., Lindgren, Cecilia M., Rayner, Nigel W., Timpson, Nicholas J., Zeggini, Eleftheria, Newport, Melanie, Sirugo, Giorgio, Lyons, Emily, Vannberg, Fredrik, Hill, Adrian V. S., Bradbury, Linda A., Farrar, Claire, Pointon, Jennifer J., Wordsworth, Paul, Brown, Matthew A., Franklyn, Jayne A., Heward, Joanne M., Simmonds, Matthew J., Gough, Stephen C. L., Seal, Sheila, Stratton, Michael R., Rahman, Nazneen, Ban, Maria, Goris, An, Sawcer, Stephen J., Compston, Alastair, Conway, David, Jallow, Muminatou, Rockett, Kirk A., Bryan, Claire, Bumpstead, Suzannah J., Chaney, Amy, Downes, Kate, Ghori, Jilur, Gwilliam, Rhian, Hunt, Sarah E., Inouye, Michael, Keniry, Andrew, King, Emma, McGinnis, Ralph, Potter, Simon, Ravindrarajah, Rathi, Whittaker, Pamela, Withers, David, Cardin, Niall J., Ferreira, Teresa, Pereira-Gale, Joanne, Hallgrimsdottir, Ingeleif B., Howie, Bryan N., Su, Zhan, Ying Teo, Yik, Vukcevic, Damjan, Bentley, David, and Compston, Alistair
- Subjects
Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Author(s): Sergey Nejentsev [1, 57]; Joanna M. M. Howson (corresponding author) [1, 57]; Neil M. Walker [1]; Jeffrey Szeszko [1]; Sarah F. Field [1]; Helen E. Stevens [1]; Pamela Reynolds [...]
- Published
- 2007
- Full Text
- View/download PDF
188. Lanthanide labeling offers fast NMR approach to 3D structure determinations of protein-protein complexes
- Author
-
Pintacuda, Guido, Ah Young Park, Keniry, Max A., Dixon, Nicholas E., and Otting, Gottfried
- Subjects
Rare earth metals -- Chemical properties ,Rare earth metals -- Spectra ,Nuclear magnetic resonance -- Observations ,Proteins -- Structure ,Proteins -- Spectra ,Chemistry - Abstract
A novel nuclear magnetic resonance (NMR) strategy based on labeling with lanthanides has achieved rapid determinations of accurate three-dimensional (3D) structures of protein-protein complexes. This method has used pseudocontact shifts (PCS) that are induced by a site-specifically bound lanthanide ion in order to anchor the coordinate system of the magnetic susceptibility tensor in the molecular frames of the two molecules.
- Published
- 2006
189. Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study
- Author
-
Panos Deloukas, Dyfrig A. Hughes, David Fitzmaurice, Paula R Williamson, Farhad Kamali, Cheng H. Toh, Munir Pirmohamed, Andrea L. Jorgensen, Alison J. Coffey, Brian Kevin Park, Jieying Eunice Zhang, Karen Hawkins, Anita Hanson, Lisa Stevens, Diane Van Eker, Andrew Keniry, Ann K. Daly, and Sameh Alzubiedi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Genotype ,medicine.drug_class ,Environment ,Article ,Mixed Function Oxygenases ,Vitamin K Epoxide Reductases ,Internal medicine ,Genetic variation ,Genetics ,medicine ,Cytochrome P-450 CYP3A ,Humans ,General Pharmacology, Toxicology and Pharmaceutics ,Intensive care medicine ,Prospective cohort study ,Molecular Biology ,CYP2C9 ,Genetics (clinical) ,Aged ,Cytochrome P-450 CYP2C9 ,Aged, 80 and over ,business.industry ,Anticoagulant ,Warfarin ,Anticoagulants ,Genetic Variation ,Middle Aged ,Cytochrome P-450 CYP2C19 ,Clinical trial ,Treatment Outcome ,Endocrinology ,Molecular Medicine ,Female ,Aryl Hydrocarbon Hydroxylases ,VKORC1 ,business ,Pharmacogenetics ,medicine.drug - Abstract
In this prospective cohort study, we have undertaken a comprehensive evaluation of clinical parameters along with variation in 29 genes (including CYP2C9 and VKORC1) to identify factors determining interindividual variability in warfarin response.Consecutive patients (n=311) were followed up prospectively for 26 weeks. Several outcomes chosen to capture both warfarin efficacy and toxicity were assessed. Univariate and multiple regression analyses were undertaken to assess the combined effect of clinical and genetic factors.CYP2C9 was the most important gene determining initial anticoagulant control, whereas VKORC1 was more important for stable anticoagulation. Novel associations with some clinical outcomes were found with single nucleotide polymorphisms in the cytochrome 450 genes CYP2C18 and CYP2C19, which were independent of the associations observed with CYP2C9 and in genes encoding CYP3A5, protein S and clotting factor V, although the variability explained by these genes was small. On the basis of the results of microcosting, adverse events were shown to be a significant predictor of total cost.Accurate prediction of warfarin dose requirement needs to take into account multiple genetic and environmental factors, the contributions of which vary in the induction and maintenance phases of treatment.
- Published
- 2009
- Full Text
- View/download PDF
190. Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a
- Author
-
Hanina Hibshoosh, Matthew Maurer, Lao H. Saal, Megan Keniry, Benjamin D. Hopkins, Barry Fine, Tao Su, Ramon Parsons, Cindy Hodakoski, Susan Koujak, Maria Luisa Sulis, and Sarah M. Mense
- Subjects
Male ,Tumor suppressor gene ,Breast Neoplasms ,Biology ,medicine.disease_cause ,Article ,Cell Line ,Phosphatidylinositol 3-Kinases ,Cell Line, Tumor ,Neoplasms ,medicine ,Guanine Nucleotide Exchange Factors ,Humans ,PTEN ,Tensin ,Phosphorylation ,PI3K/AKT/mTOR pathway ,Cell Proliferation ,Multidisciplinary ,Cell growth ,GTPase-Activating Proteins ,PTEN Phosphohydrolase ,Protein Structure, Tertiary ,Lipid phosphatase activity ,Mutation ,Cancer cell ,Cancer research ,biology.protein ,Female ,Carcinogenesis ,Proto-Oncogene Proteins c-akt ,Protein Binding ,Signal Transduction - Abstract
Reigning In Tumor Suppression Mitogenic signaling through phosphoinositide-3 kinase generates the lipid second messenger phosphatidyl inositol 3,4,5-trisphosphate (PIP3). The tumor suppressor gene product and lipid phosphatase PTEN (phosphatase and tensin homolog on chromosome 10) opposes such mitogenic signaling by dephosphorylating PIP3. In a screen for proteins that interact with PTEN, Fine et al. (p. 1261 ) identified P-REX2a, a guanine nucleotide exchange factor (GEF) for the RAC small guanosine triphosphatase. Endogenous P-REX2a and PTEN interacted in human embryonic kidney 293 cells, and P-REX2a inhibited catalytic activity of PTEN. Thus, like that of many protein phosphatases, the activity of PTEN is kept in check by an interacting protein inhibitor. P-REX2a thus provides a mechanism through which tumor cells may inactivate PTEN.
- Published
- 2009
- Full Text
- View/download PDF
191. Migration Characteristics of Hatchery and Natural Spring Chinook Salmon Smolts from the Grande Ronde River Basin, Oregon, to Lower Granite Dam on the Snake River
- Author
-
Peter J. Cleary, Timothy L. Hoffnagle, Patrick J. Keniry, Brian C. Jonasson, Fred R. Monzyk, and Richard W. Carmichael
- Subjects
geography ,Chinook wind ,geography.geographical_feature_category ,biology ,Drainage basin ,Aquatic animal ,Aquatic Science ,biology.organism_classification ,Hatchery ,Natural (archaeology) ,Travel time ,Fishery ,Spring (hydrology) ,Oncorhynchus ,Environmental science ,Ecology, Evolution, Behavior and Systematics - Abstract
Smolts of spring Chinook salmon Oncorhynchus tshawytscha experience substantial mortality while migrating through free-flowing reaches of the Snake River basin before reaching Lower Granite Dam, the first dam encountered in the Columbia-Snake river hydrosystem. We investigated the patterns of travel time and survival of hatchery and natural smolts fitted with passive integrated transponder (PIT) tags through specific reaches of the migration corridor during the 2000-2006 migration years for two populations originating in the Grande Ronde River basin (Lostine River and Catherine Creek). For both populations, median travel times for natural smolts were significantly longer in the upper reaches of the migration corridor but shorter in the lower reaches than for their hatchery counterparts. Also, among both hatchery and natural smolts, smaller individuals spent more time in the upper reaches, presumably feeding to attain a larger size before continuing their migration. Within populations, both hatche...
- Published
- 2009
- Full Text
- View/download PDF
192. Genome-wide and fine-resolution association analysis of malaria in West Africa
- Author
-
Muminatou, Jallow, Yik Ying Teo, Small, Kerrin S., Rockett, Kirk A., Panos, Deloukas, Clark, Taane G., Katja, Kivinen, Bojang, Kalifa A., Conway, David J., Margaret, Pinder, Giorgio, Sirugo, Fatou Sisay Joof, Stanley, Usen, Sarah, Auburn, Bumpstead, Suzannah J., Susana, Campino, Alison, Coffey, Andrew, Dunham, Fry, Andrew E., Angela, Green, Rhian, Gwilliam, Hunt, Sarah E., Michael, Inouye, Jeffreys, Anna E., Alieu, Mendy, Aarno, Palotie, Simon, Potter, Jiannis, Ragoussis, Jane, Rogers, Kate, Rowlands, Elilan, Somaskantharajah, Pamela, Whittaker, Claire, Widden, Peter, Donnelly, Bryan, Howie, Jonathan, Marchini, Andrew, Morris, Miguel, Sanjoaquin, Eric Akum Achidi, Tsiri, Agbenyega, Angela, Allen, Olukemi, Amodu, Patrick, Corran, Abdoulaye, Djimde, Amagana, Dolo, Doumbo, Ogobara K., Chris, Drakeley, Sarah, Dunstan, Jennifer, Evans, Jeremy, Farrar, Hien Tt, Fernando D., Horstmann, R. D., Ibrahim, M., Karunaweera, N., Kokwaro, G., Koram, K. A., Lemnge, M., Makani, J., Marsh, K., Michon, P., David, Modiano, Molyneux, M. E., Mueller, I., Parker, M., Peshu, N., Plowe, C. V., Puijalon, O., Reeder, J., Reyburn, H., Riley, E. M., Sakuntabhai, A., Singhasivanon, P., Sirima, S., Tall, A., Taylor, T. E., Thera, M., Troye Blomberg, M., Williams, T. N., Wilson, M., Wellcome Trust Case Control Consortium Kwiatkowski, D. P., Epidemiology Network: Achidi, Malaria Genomic E. A., Agbenyega, T., Ahmad, T., Alcock, D., Allen, S., Amenga Etego, L., Amodu, O., Apinjoh, T. O., Attwood, A. P., Auburn, S., Ball, S. G., Balmforth, A. J., Ban, M., Barbour, J., Barnwell, D., Barrett, J. C., Barrett, J. H., Barton, A., Bentley, D., Bishop, D. T., Bojang, K., Boorman, J. P., Bougouma, E., Bradbury, L. A., Braga Marcano, C. A., Braund, P. S., Bredin, F., Breen, G., Brown, M. A., Brown, M. J., Bruce, I. N., Bryan, C., Bull, S., Bumpstead, S. J., Burke, B., Burton, P. R., Caesar, S., Campino, S., Cant, B., Cardin, N. J., Cardon, L. R., Carucci, D., Caulfield, M., Chaney, A., Clark, T., Clayton, D. G., Collier, D. A., Compston, A., Compston, D. A., Connell, J., Conway, D., Cook, K., Corran, P., Craddock, N., Cummings, F. R., Davison, D., Deloukas, P., Devries, J., Dewasurendra, R., Diakite, M., Dixon, R. J., Djimde, A., Dobson, R., Dolo, A., Dominiczak, A., Donnelly, P., Donovan, H., Doumbo, O., Downes, K., Doyle, A., Drakeley, C., Drummond, H., Duffy, P., Duncanson, A., Dunger, D. B., Dunstan, S., Duombo, O., Easton, D., Elkin, A., Elliott, K. S., Elzein, A., Enimil, A., Evans, D., Evans, J., Everson, U., Eyre, S., Farmer, A., Farrall, M., Farrar, C., Farrar, J., Fernando, D., Ferreira, T., Ferrier, I. N., Fisher, S. A., Fitzpatrick, K., Forbes, A., Franklyn, J. A., Fraser, C., Frayling, T. M., Freathy, R. M., Ghansah, A., Ghori, J., Gilbert, P. D., Gordon Smith, K., Goris, A., Gottlieb, M., Gough, S. C., Green, A., Green, E. K., Groves, C. J., Grozeva, D., Gungadoo, J., Gwilliam, R., Hall, A. S., Hallgrimsdóttir, I. B., Hamshere, M. L., Hart, L., Hattersley, A. T., Heward, J. M., Hider, S. L., Tran Tinh Hien, Hill, A. V., Hilton, E., Hinks, A. M., Hitman, G. A., Holmans, P. A., Horstmann, Rolf D., Howie, B. N., Hubbart, C., Hughes, C., Hunt, S. E., Hussein, A., Hussey, J. M., Muntaser, Ibrahim, Iles, M. M., Inouye, M., Ishengoma, D., Jallow, M., Jeffreys, A. E., Jewell, D. P., John, Sl, Jolley, J. D., Jones, I. R., Jones, L., Jones, R. W., Nadira, Karunaweera, Keniry, A., King, E., Kirov, G., Kivinen, K., Knight, A. S., Koch, K., Gilbert, Kokwaro, Koram, Kwadwo A., Lango, H., Lathrop, G. M., Lee, K. L., Lees, C. W., Martha, Lemnge, Leung, H. T., Lewis, C. M., Lin, E., Lindgren, C. M., Ly, A., Macinnis, B., Julie, Makani, Mangano, Valentina, Mangino, M., Manjurano, A., Manning, L., Mansfield, J. C., Manske, M., Maqbool, A., Marchini, J. L., Kevin, Marsh, Maslen, G., Mathew, C. G., Mcardle, W. L., Mccarthy, M. I., Mccreight, M., Mcginnis, R., Mcguffin, P., Meech, E., Mendy, A., Pascal, Michon, Mohiuddin, M. K., Molyneux, Malcolm E., Morris, A. P., Moskvina, V., Moyes, C., Ivo, Mueller, Munroe, P. B., Mutabingwa, T., Ndila, C. M., Newhouse, S. J., Newport, M., Nikolov, I., Nimmo, E. R., Nutland, S., Nyirongo, V., O'Donovan, M. C., Oluoch, T., Onipinla, A., Onnie, C. M., Ouwehand, W. H., Owen, M. J., Michael, Parker, Parkes, M., Pembrey, M., Pereira Gale, J., Perry, J. R., Norbert, Peshu, Plowe, Christopher V., Pointon, J. J., Potter, C., Potter, S., Prescott, N. J., Prowse, C. V., Odile, Puijalon, Quyen, N. T., Ragoussis, J., Rahman, N., Ravindrarajah, R., Rayner, N. W., John, Reeder, Hugh, Reyburn, Riley, Eleanor M., Ring, S. M., Risley, P., Rockett, K. A., Rogers, J., Rowlands, K., Anavaj, Sakuntabhai, Samani, N. J., Sanderson, J., Sanjoaquin, M., Satsangi, J., Sawcer, S. J., Seal, S., Shields, B. M., Silman, A. J., Simmonds, M. J., Pratap, Singhasivanon, Sodiomon, Sirima, Sirugo, G., Small, K. S., Somaskantharajah, E., Spencer, C. C., St Clair, D., Stevens, H. E., Stevens, M., Stevens, S., Strachan, D. P., Stratton, M. R., Su, Z., Suriyaphol, P., Symmons, D. P., Adama, Tall, Taylor, N. C., Taylor, Terrie E., Teo, Y., Teo, Y. Y., Mahamadou, Thera, Thompson, J. R., Thomson, W., Timpson, N. J., Tobin, M. D., Todd, J. A., Todhunter, C. E., Toure, O., Tremelling, M., Marita Troye Blomberg, Vanderwal, A., Vukcevic, D., Walker, M., Walker, N. M., Wallace, C., Walters, G. R., Walton, R., Watkins, N. A., Watson, R., Webster, J., Weedon, M. N., Whittaker, P., Widmer, B., Williams, Thomas N., Williamson, R., Michael, Wilson, Winzer, T., Withers, D., Wordsworth, P., Worthington, J., Wrigley, R., Xue, M., Young, A. H., Yuldasheva, N., and Zeggini, E.
- Subjects
Linkage disequilibrium ,Hemoglobin, Sickle ,Population ,Genome-wide association study ,Locus (genetics) ,Biology ,Population stratification ,Polymorphism, Single Nucleotide ,Severity of Illness Index ,Linkage Disequilibrium ,Article ,Gene mapping ,Reference Values ,Ethnicity ,Genetics ,Humans ,education ,Genetic association ,education.field_of_study ,Polymorphism, Genetic ,Chromosome Mapping ,Genetic Variation ,Malaria ,Gambia ,Imputation (genetics) ,Genome-Wide Association Study - Abstract
We report a genome-wide association (GWA) study of severe malaria in The Gambia. The initial GWA scan included 2,500 children genotyped on the Affymetrix 500K GeneChip, and a replication study included 3,400 children. We used this to examine the performance of GWA methods in Africa. We found considerable population stratification, and also that signals of association at known malaria resistance loci were greatly attenuated owing to weak linkage disequilibrium (LD). To investigate possible solutions to the problem of low LD, we focused on the HbS locus, sequencing this region of the genome in 62 Gambian individuals and then using these data to conduct multipoint imputation in the GWA samples. This increased the signal of association, from P = 4 × 10(-7) to P = 4 × 10(-14), with the peak of the signal located precisely at the HbS causal variant. Our findings provide proof of principle that fine-resolution multipoint imputation, based on population-specific sequencing data, can substantially boost authentic GWA signals and enable fine mapping of causal variants in African populations.
- Published
- 2009
- Full Text
- View/download PDF
193. A Comprehensive Survey of Single Nucleotide Polymorphisms (SNPs) across Mycobacterium bovis Strains and M. bovis BCG Vaccine Strains Refines the Genealogy and Defines a Minimal Set of SNPs That Separate Virulent M. bovis Strains and M. bovis BCG Strains
- Author
-
Thierry Garnier, R. Glyn Hewinson, Stewart T. Cole, Julian Parkhill, Javier Nunez Garcia, Xiangmei Zhou, Pablo Mendoza Lopez, Noel H. Smith, Laura Boschiroli, Stephen V. Gordon, M. Carmen Garcia Pelayo, Swapna Uplekar, and Andrew Keniry
- Subjects
Genetics ,Mycobacterium bovis ,Immunology ,Virulence ,Single-nucleotide polymorphism ,Biology ,biology.organism_classification ,complex mixtures ,Microbiology ,Virology ,Infectious Diseases ,DNA profiling ,Genetic marker ,Genotype ,Parasitology ,Tuberculosis vaccines ,BCG vaccine - Abstract
To further unravel the mechanisms responsible for attenuation of the tuberculosis vaccine Mycobacterium bovis BCG, comparative genomics was used to identify single nucleotide polymorphisms (SNPs) that differed between sequenced strains of Mycobacterium bovis and M. bovis BCG. SNPs were assayed in M. bovis isolates from France and the United Kingdom and from different BCG vaccines in order to identify those that arose during the attenuation process which gave rise to BCG. Informative data sets were obtained for 658 SNPs from 21 virulent M. bovis strains and 13 BCG strains; these SNPs showed phylogenetic clustering that was consistent with the geographical origin of the strains and previous schemes for BCG genealogies. The data revealed a closer relationship between BCG Tice and BCG Pasteur than was previously appreciated, while we were able to position BCG Beijing within a grouping of BCG Denmark-derived strains. Only 186 SNPs were identified between virulent M. bovis strains and all BCG strains, with 115 nonsynonymous SNPs affecting important functions such as global regulators, transcriptional factors, and central metabolism, which might impact on virulence. We therefore refine previous genealogies of BCG vaccines and define a minimal set of SNPs between virulent M. bovis strains and the attenuated BCG strain that will underpin future functional analyses.
- Published
- 2009
- Full Text
- View/download PDF
194. Kaposi sarcoma incidence in females is nearly four-fold higher in the Lower Rio Grande Valley compared to the Texas average
- Author
-
Innis-Whitehouse, Wendy, primary, Wang, Xiaohui, additional, Restrepo, Nicolas, additional, Salas, Carlos, additional, Moreno, Katia, additional, Restrepo, Alvaro, additional, and Keniry, Megan, additional
- Published
- 2018
- Full Text
- View/download PDF
195. Oxidative insults disrupt OPA1-mediated mitochondrial dynamics in cultured mammalian cells
- Author
-
Garcia, Iraselia, primary, Innis-Whitehouse, Wendy, additional, Lopez, Alma, additional, Keniry, Megan, additional, and Gilkerson, Robert, additional
- Published
- 2018
- Full Text
- View/download PDF
196. The role of PTEN signaling perturbations in cancer and in targeted therapy
- Author
-
Ramon Parsons and Megan Keniry
- Subjects
Cancer Research ,Tumor suppressor gene ,medicine.medical_treatment ,Antineoplastic Agents ,medicine.disease_cause ,Models, Biological ,Targeted therapy ,Drug Delivery Systems ,Neoplasms ,Genetics ,medicine ,Humans ,PTEN ,Molecular Biology ,Protein kinase B ,PI3K/AKT/mTOR pathway ,biology ,PTEN Phosphohydrolase ,Cancer ,Prognosis ,medicine.disease ,Treatment Outcome ,Drug Resistance, Neoplasm ,biology.protein ,Cancer research ,Signal transduction ,Carcinogenesis ,Signal Transduction - Abstract
The PTEN tumor suppressor was discovered by its homozygous deletion and other mutations in cancer. Since then, PTEN has been shown to be a non-redundant, evolutionarily conserved phosphatase whose function affects diverse cellular progresses such as cell cycle progression, cell proliferation, chemotaxis, apoptosis, aging, muscle contractility, DNA damage response, angiogenesis and cell polarity. In accordance with its ability to influence multiple crucial cellular processes, PTEN has a major role in the pathogenesis of numerous diseases such as diabetes, autism and almost every cancer examined. This review will discuss the diverse ways in which PTEN signaling is modified in cancer, and how these changes correlate with and might possibly affect the action of targeted chemotherapy.
- Published
- 2008
- Full Text
- View/download PDF
197. A Triad of Bis(orthometalated) d8-Complexes Containing Four-Membered Rings
- Author
-
Jörg Wagler, Peta Simmonds, Suresh K. Bhargava, Max A. Keniry, Steven H. Privér, Martin A. Bennett, and Anthony C. Willis
- Subjects
Organic Chemistry ,Inorganic chemistry ,chemistry.chemical_element ,Zinc ,Medicinal chemistry ,Inorganic Chemistry ,Bipyridine ,chemistry.chemical_compound ,Nickel ,chemistry ,Physical and Theoretical Chemistry ,Diethyl ether ,Platinum ,Lone pair ,Palladium ,Carbon monoxide - Abstract
Reaction of 2-LiC6F4PPh2 with [MCl2(SEt2)2] in diethyl ether gives the monomeric bis(chelate) complexes trans-[M(κ2-2-C6F4PPh2)2] [M = Pt (1), Pd (2)] or, in the case of platinum, a mixture of cis- and trans-isomers. Treatment of a mixture of NiCl2 and 2-BrC6F4PPh2 in THF with zinc dust gives trans-[Ni(κ2-2-C6F4PPh2)2] (3). The four-membered chelate rings in 1−3 are opened on addition of the bidentate ligand 1,2-bis(diphenylphosphino)ethane (dppe), and, in the case of 3, 2,2′-bipyridine (bipy) and 1,10-phenanthroline (phen), to give complexes of the type cis-[M(κC-C6F4-2-PPh2)2(L-L)] [L-L = dppe, M = Ni (6), Pd (7), Pt (8); M = Ni, L-L = bipy (9), phen (10)], in which the PPh2 groups are uncoordinated. Complexes 6−8 show unexpectedly large four-bond coupling constants (4JPF), in the range 75−95 Hz, between the fluorine atoms (F6) ortho to the metal−carbon σ-bond and the phosphorus atoms of the PPh2 groups, possibly because F6 and the lone pairs on phosphorus adopt a close to synperiplanar conformation. Tr...
- Published
- 2008
- Full Text
- View/download PDF
198. The Solution Conformation of a Trisdecanucleotide Containing the Consensus Binding Site of the dnaA Initiation Protein
- Author
-
Max A. Keniry, Elisabeth A. Owen, and Barry N. Gray
- Subjects
DNA Replication ,Binding Sites ,Magnetic Resonance Spectroscopy ,Base Sequence ,Oligonucleotide ,Stereochemistry ,Chemistry ,Molecular Sequence Data ,Stacking ,Phosphorus Isotopes ,Curvature ,Biochemistry ,DnaA ,DNA-Binding Proteins ,Crystallography ,Molecular dynamics ,Bacterial Proteins ,Oligodeoxyribonucleotides ,Consensus Sequence ,Nucleic Acid Conformation ,Relaxation matrix ,Protons ,Binding site ,Purine metabolism ,Protein Binding - Abstract
The solution structure of a trisdecanucleotide, d(CCTGTGGATAACA).d(TGTTATCCACAGG) containing the consensus binding site of the dnaA initiation protein has been determined by two-dimensional NMR techniques and restrained molecular dynamics calculations. Interproton distances were obtained by an iterative complete relaxation matrix algorithm, MARDIGRAS. During molecular dynamics runs, the backbone was restricted with the assistance of experimentally derived distance constraints. A family of refined structures with small pairwise root-mean-square deviation values (approximately 0.08 nm) was obtained. All but one of the pyrimidines were found to adopt the C1'-exo conformation while the purines were found to adopt the C2'-endo or C1'-exo conformation. The six-membered rings of the purines were found to stack over the six-membered rings of the pyrimidines while there is virtually no overlap of the pyrimidines over the purines. 5'-purine-purine-3' and 5'-pyrimidine-pyrimidine-3' stacking resembles the observed stacking of these bases in other NMR and X-ray structures of oligonucleotides. The final refined structure exhibited a small curvature and was slightly longer than canonical B-DNA. The variation of twist angle, proposed as a recognition element for proteins, exhibited symmetry about the centre of the consensus binding site.
- Published
- 2008
- Full Text
- View/download PDF
199. PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer
- Author
-
Xiaomei Wang, Mahesh Mansukhani, Satoru Nagase, B. Tycko, Hanina Hibshoosh, Megan Keniry, Lorenzo Memeo, Chi Ming Li, Ramon Parsons, Tao Su, A. Rojtman, Susan Koujak, and Jennifer S. Yu
- Subjects
Cancer Research ,Cell signaling ,Tumor suppressor gene ,DNA Mutational Analysis ,Breast Neoplasms ,Cell Communication ,Biology ,medicine.disease_cause ,Article ,Mice ,Cyclin D1 ,Growth factor receptor ,Cell Movement ,Epidermal growth factor ,Sequence Homology, Nucleic Acid ,Tumor Cells, Cultured ,Genetics ,medicine ,Animals ,Humans ,Genes, Tumor Suppressor ,Mammary Glands, Human ,Promoter Regions, Genetic ,Molecular Biology ,Base Sequence ,DNA Methylation ,Cell cycle ,Cadherins ,Protocadherins ,Gene Expression Regulation, Neoplastic ,Cell Transformation, Neoplastic ,Mutation ,DNA methylation ,Cancer research ,Carcinogenesis ,Gene Deletion - Abstract
Carcinoma is an altered state of tissue differentiation in which epithelial cells no longer respond to cues that keep them in their proper position. A break down in these cues has disastrous consequences not only in cancer but also in embryonic development when cells of various lineages must organize into discrete entities to form a body plan. Paraxial protocadherin (PAPC) is an adhesion protein with six cadherin repeats that organizes the formation and polarity of developing cellular structures in frog, fish and mouse embryos. Here we show that protocadherin-8 (PCDH8), the human ortholog of PAPC, is inactivated through either mutation or epigenetic silencing in a high fraction of breast carcinomas. Los s of PCDH8 expression is associated with loss of heterozygosity, partial promoter methylation, and increased proliferation. Complementation of mutant tumor cell line HCC2218 with wild-type PCDH8 inhibited its growth. Two tumor mutants, E146K and R343H, were defective for inhibition of cell growth and migration. Surprisingly, the E146K mutant transformed the human mammary epithelial cell line MCF10A and sustained the expression of cyclin D1 and MYC without epidermal growth factor. We propose that loss of PCDH8 promotes oncogenesis in epithelial human cancers by disrupting cell–cell communication dedicated to tissue organization and repression of mitogenic signaling.
- Published
- 2008
- Full Text
- View/download PDF
200. Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease
- Author
-
Stefan Blankenberg, Alistair S. Hall, Ralph McGinnis, Peter S. Braund, Alison H. Goodall, Richard J. Dixon, Nilesh J. Samani, Inke R. König, Daniel F Schwarz, Christian Hengstenberg, Andrew Keniry, John R. Thompson, Jeanette Erdmann, François Cambien, Nour Eddine El Mokhtari, Stefan Schreiber, Massimo Mangino, Panos Deloukas, Willem H. Ouwehand, Klaus Stark, Pierre Ducimetière, Marcus Fischer, Laurence Tiret, Andreas Ziegler, Christa Meisinger, Henrike Liptau, H.-Erich Wichmann, Anika Götz, Helen Pollard, David-Alexandre Trégouët, Mohammed J. R. Ghori, Patrick Linsel-Nitschke, Heribert Schunkert, and Ludwig A. Hothorn
- Subjects
Genetic Markers ,Male ,Oncology ,medicine.medical_specialty ,Genotype ,Locus (genetics) ,Single-nucleotide polymorphism ,Coronary Artery Disease ,Bioinformatics ,Polymorphism, Single Nucleotide ,Article ,Coronary artery disease ,Risk Factors ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,SNP ,Prospective Studies ,Aged ,Repetitive Sequences, Nucleic Acid ,Genetic association ,business.industry ,Haplotype ,Case-control study ,Genetic Variation ,Odds ratio ,Middle Aged ,medicine.disease ,Case-Control Studies ,Female ,Chromosomes, Human, Pair 9 ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background— Recently, genome-wide association studies identified variants on chromosome 9p21.3 as affecting the risk of coronary artery disease (CAD). We investigated the association of this locus with CAD in 7 case-control studies and undertook a meta-analysis. Methods and Results— A single-nucleotide polymorphism (SNP), rs1333049, representing the 9p21.3 locus, was genotyped in 7 case-control studies involving a total of 4645 patients with myocardial infarction or CAD and 5177 controls. The mode of inheritance was determined. In addition, in 5 of the 7 studies, we genotyped 3 additional SNPs to assess a risk-associated haplotype (ACAC). Finally, a meta-analysis of the present data and previously published samples was conducted. A limited fine mapping of the locus was performed. The risk allele (C) of the lead SNP, rs1333049, was uniformly associated with CAD in each study ( P P =0.0001). Haplotype analysis further suggested that this effect was not homogeneous across the haplotypic background (test for interaction, P =0.0079). An autosomal-additive mode of inheritance best explained the underlying association. The meta-analysis of the rs1333049 SNP in 12 004 cases and 28 949 controls increased the overall level of evidence for association with CAD to P =6.04×10 −10 (odds ratio, 1.24; 95% confidence interval, 1.20 to 1.29). Genotyping of 31 additional SNPs in the region identified several with a highly significant association with CAD, but none had predictive information beyond that of the rs1333049 SNP. Conclusion— This broad replication provides unprecedented evidence for association between genetic variants at chromosome 9p21.3 and risk of CAD.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.